FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3111162904> ?p ?o ?g. }

• W3111162904 endingPage "1241" @default.
• W3111162904 startingPage "1241" @default.
• W3111162904 abstract "It has recently been demonstrated that chronic supplementation with nonanimal chondroitin sulfate (nonanimal CS) in overweight subjects with knee osteoarthritis (OA) improves the function, pain and inflammation, but there are no studies of its effectiveness in an acute setting. In 48 obese subjects with moderate knee OA, we investigated the effectiveness of nonanimal CS supplementation for eight weeks on the inflammation, functional status, oxidative stress, cartilage catabolism markers, metabolic profile and body composition, by Dual-Energy X-ray Absorptiometry (DXA) at the baseline, after 15 days and at the end of the eight-week study. To evaluate the acute effectiveness on inflammation, 15-min cycle training sessions were done 15 days after the start of the study and at the end. C-reactive protein (CRP) was assayed in blood samples collected before and after the two cycling exercises. The 48 obese subjects (M and F, 20–50 years, body mass index (BMI) 30–35 kg/m2) were randomly assigned to an experimental group (N = 24, 600-mg tablet of nonanimal CS/day) or the control group (N = 24, placebo). The between-groups analysis of covariance showed a significant effect on the Western Ontario and McMaster Universities Arthritis index (WOMAC) scale (p = 0.000) and CRP (p = 0.022). For intra-group differences, the result was significant in the CS group for BMI, WOMAC, CRP, total cholesterol and Homeostasis Model Assessment (HOMA). In these obese adults with OA, nonanimal CS improved the inflammation, knee function, metabolic profile and body composition." @default.
• W3111162904 created "2020-12-21" @default.
• W3111162904 creator A5003425878 @default.
• W3111162904 creator A5004061491 @default.
• W3111162904 creator A5037695210 @default.
• W3111162904 creator A5043613931 @default.
• W3111162904 creator A5043673721 @default.
• W3111162904 creator A5046576009 @default.
• W3111162904 creator A5048032678 @default.
• W3111162904 creator A5067829004 @default.
• W3111162904 creator A5067853047 @default.
• W3111162904 creator A5076662441 @default.
• W3111162904 creator A5083601116 @default.
• W3111162904 creator A5083916718 @default.
• W3111162904 creator A5091641213 @default.
• W3111162904 date "2020-12-07" @default.
• W3111162904 modified "2023-09-24" @default.
• W3111162904 title "Short- and Long-Term Effectiveness of Supplementation with Non-Animal Chondroitin Sulphate on Inflammation, Oxidative Stress and Functional Status in Obese Subjects with Moderate Knee Osteoarthritis before and after Physical Stress: A Randomized, Double-Blind, Placebo-Controlled Trial" @default.
• W3111162904 cites W1497104265 @default.
• W3111162904 cites W1546820319 @default.
• W3111162904 cites W1558552946 @default.
• W3111162904 cites W1976982011 @default.
• W3111162904 cites W2006547235 @default.
• W3111162904 cites W2007582187 @default.
• W3111162904 cites W2010760524 @default.
• W3111162904 cites W2046897713 @default.
• W3111162904 cites W2051446426 @default.
• W3111162904 cites W2073755736 @default.
• W3111162904 cites W2076963888 @default.
• W3111162904 cites W2081194447 @default.
• W3111162904 cites W2087139148 @default.
• W3111162904 cites W2091218396 @default.
• W3111162904 cites W2113737049 @default.
• W3111162904 cites W2115805053 @default.
• W3111162904 cites W2127647469 @default.
• W3111162904 cites W2135532785 @default.
• W3111162904 cites W2147148117 @default.
• W3111162904 cites W2158419538 @default.
• W3111162904 cites W2166076573 @default.
• W3111162904 cites W2227341519 @default.
• W3111162904 cites W2337796195 @default.
• W3111162904 cites W2520631890 @default.
• W3111162904 cites W2586442340 @default.
• W3111162904 cites W2591726958 @default.
• W3111162904 cites W2624174818 @default.
• W3111162904 cites W2804410140 @default.
• W3111162904 cites W2808020555 @default.
• W3111162904 cites W2922173769 @default.
• W3111162904 cites W2970748471 @default.
• W3111162904 cites W3021207798 @default.
• W3111162904 doi "https://doi.org/10.3390/antiox9121241" @default.
• W3111162904 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7762287" @default.
• W3111162904 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33297347" @default.
• W3111162904 hasPublicationYear "2020" @default.
• W3111162904 type Work @default.
• W3111162904 sameAs 3111162904 @default.
• W3111162904 citedByCount "6" @default.
• W3111162904 countsByYear W31111629042021 @default.
• W3111162904 countsByYear W31111629042022 @default.
• W3111162904 countsByYear W31111629042023 @default.
• W3111162904 crossrefType "journal-article" @default.
• W3111162904 hasAuthorship W3111162904A5003425878 @default.
• W3111162904 hasAuthorship W3111162904A5004061491 @default.
• W3111162904 hasAuthorship W3111162904A5037695210 @default.
• W3111162904 hasAuthorship W3111162904A5043613931 @default.
• W3111162904 hasAuthorship W3111162904A5043673721 @default.
• W3111162904 hasAuthorship W3111162904A5046576009 @default.
• W3111162904 hasAuthorship W3111162904A5048032678 @default.
• W3111162904 hasAuthorship W3111162904A5067829004 @default.
• W3111162904 hasAuthorship W3111162904A5067853047 @default.
• W3111162904 hasAuthorship W3111162904A5076662441 @default.
• W3111162904 hasAuthorship W3111162904A5083601116 @default.
• W3111162904 hasAuthorship W3111162904A5083916718 @default.
• W3111162904 hasAuthorship W3111162904A5091641213 @default.
• W3111162904 hasBestOaLocation W31111629041 @default.
• W3111162904 hasConcept C105702510 @default.
• W3111162904 hasConcept C126322002 @default.
• W3111162904 hasConcept C134018914 @default.
• W3111162904 hasConcept C142724271 @default.
• W3111162904 hasConcept C153074725 @default.
• W3111162904 hasConcept C1862650 @default.
• W3111162904 hasConcept C204787440 @default.
• W3111162904 hasConcept C27081682 @default.
• W3111162904 hasConcept C2776151105 @default.
• W3111162904 hasConcept C2776164576 @default.
• W3111162904 hasConcept C2776914184 @default.
• W3111162904 hasConcept C2779286237 @default.
• W3111162904 hasConcept C2779553658 @default.
• W3111162904 hasConcept C2780221984 @default.
• W3111162904 hasConcept C2780586474 @default.
• W3111162904 hasConcept C71924100 @default.
• W3111162904 hasConceptScore W3111162904C105702510 @default.
• W3111162904 hasConceptScore W3111162904C126322002 @default.
• W3111162904 hasConceptScore W3111162904C134018914 @default.
• W3111162904 hasConceptScore W3111162904C142724271 @default.
• W3111162904 hasConceptScore W3111162904C153074725 @default.
• W3111162904 hasConceptScore W3111162904C1862650 @default.
• W3111162904 hasConceptScore W3111162904C204787440 @default.

• next